Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...
A new AI-powered tech is showing law enforcement and public health leaders dangerous drugs entering their communities and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback